Antiva Biosciences   Report issue

For profit Phase 1
Founded: Del Mar CA United States (2012)

Organization Overview

First Clinical Trial
2017
NCT03202992
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Antiva Biosciences